U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Burrell Terry-Ann (0001786484)
Mailing Address
C/O BEAM THERAPEUTICS INC.
26 LANDSDOWNE STREET
CAMBRIDGE MA 02139
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Rapport Therapeutics, Inc.
Current Name:
0002012593 2024-06-06 director
RECURSION PHARMACEUTICALS, INC. 0001601830 2021-04-15 director
Beam Therapeutics Inc.
Current Name:
0001745999 2020-02-05 officer: CFO


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-07-01   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 1843.0000 71254.0000 1 0001601830 Class A Common Stock
A 2024-06-03   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 26193.0000 26193.0000 2 0001601830 Stock Option (Right to Buy)
A 2024-06-03   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 13097.0000 69411.0000 1 0001601830 Class A Common Stock
A 2024-04-26   Beam Therapeutics Inc. 4 A-Award --D 25000.0000 25000.0000 2 0001745999 Stock Option (Right to Buy)
A 2024-04-26   Beam Therapeutics Inc. 4 A-Award --D 12500.0000 82637.0000 1 0001745999 Common Stock
A 2024-04-01   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 1467.0000 56314.0000 1 0001601830 Class A Common Stock
D 2024-04-01   Beam Therapeutics Inc. 4 S-Sale --D 5446.0000 70137.0000 1 0001745999 Common Stock
A 2024-03-31   Beam Therapeutics Inc. 4 A-Award --D 27500.0000 75583.0000 1 0001745999 Common Stock
A 2024-01-31   Beam Therapeutics Inc. 4 A-Award --D 55000.0000 55000.0000 1 0001745999 Stock Option (Right to Buy)
D 2023-07-13   RECURSION PHARMACEUTICALS, INC. 4 S-Sale --D 8275.0000 54847.0000 5 0001601830 Class A Common Stock
D 2023-07-12   RECURSION PHARMACEUTICALS, INC. 4 S-Sale --D 3157.0000 63122.0000 4 0001601830 Class A Common Stock
D 2023-07-12   RECURSION PHARMACEUTICALS, INC. 4 S-Sale --D 3195.0000 66279.0000 3 0001601830 Class A Common Stock
D 2023-07-12   RECURSION PHARMACEUTICALS, INC. 4 S-Sale --D 78071.0000 69474.0000 2 0001601830 Class A Common Stock
D 2023-07-12   RECURSION PHARMACEUTICALS, INC. 4 S-Sale --D 24302.0000 147545.0000 1 0001601830 Class A Common Stock
A 2023-06-16   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 25224.0000 25224.0000 2 0001601830 Stock Option (Right to Buy)
A 2023-06-16   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 12612.0000 171847.0000 1 0001601830 Class A Common Stock
D 2023-04-04   Beam Therapeutics Inc. 4 S-Sale --D 2186.0000 47117.0000 2 0001745999 Common Stock
D 2023-04-03   Beam Therapeutics Inc. 4 S-Sale --D 2454.0000 49303.0000 1 0001745999 Common Stock
A 2023-03-31   Beam Therapeutics Inc. 4 A-Award --D 20000.0000 51277.0000 1 0001745999 Common Stock
A 2023-01-31   Beam Therapeutics Inc. 4 A-Award --D 20000.0000 20000.0000 2 0001745999 Stock Option (Right to Buy)
A 2023-01-31   Beam Therapeutics Inc. 4/A A-Award --D 40000.0000 40000.0000 1 0001745999 Stock Option (Right to Buy)
D 2023-01-27   Beam Therapeutics Inc. 4 M-Exempt --D 36152.0000 185565.0000 6 0001745999 Stock Option (Right to Buy)
D 2023-01-27   Beam Therapeutics Inc. 4 S-Sale --D 36152.0000 31277.0000 4 0001745999 Common Stock
A 2023-01-27   Beam Therapeutics Inc. 4 M-Exempt --D 36152.0000 67429.0000 3 0001745999 Common Stock
D 2023-01-26   Beam Therapeutics Inc. 4 M-Exempt --D 1102.0000 221717.0000 5 0001745999 Stock Option (Right to Buy)
D 2023-01-26   Beam Therapeutics Inc. 4 S-Sale --D 1102.0000 31277.0000 2 0001745999 Common Stock
A 2023-01-26   Beam Therapeutics Inc. 4 M-Exempt --D 1102.0000 32379.0000 1 0001745999 Common Stock
D 2023-01-24   Beam Therapeutics Inc. 4 S-Sale --D 14810.0000 31277.0000 4 0001745999 Common Stock
A 2023-01-24   Beam Therapeutics Inc. 4 M-Exempt --D 14810.0000 46087.0000 3 0001745999 Common Stock
D 2023-01-24   Beam Therapeutics Inc. 4 M-Exempt --D 14810.0000 222819.0000 6 0001745999 Stock Option (Right to Buy)
D 2023-01-23   Beam Therapeutics Inc. 4 M-Exempt --D 5426.0000 237629.0000 5 0001745999 Stock Option (Right to Buy)
D 2023-01-23   Beam Therapeutics Inc. 4 S-Sale --D 5426.0000 31277.0000 2 0001745999 Common Stock
A 2023-01-23   Beam Therapeutics Inc. 4 M-Exempt --D 5426.0000 36703.0000 1 0001745999 Common Stock
D 2023-01-18   Beam Therapeutics Inc. 4 M-Exempt --D 39886.0000 243055.0000 3 0001745999 Stock Option (Right to Buy)
D 2023-01-18   Beam Therapeutics Inc. 4 S-Sale --D 47195.0000 31277.0000 2 0001745999 Common Stock
A 2023-01-18   Beam Therapeutics Inc. 4 M-Exempt --D 39886.0000 78472.0000 1 0001745999 Common Stock
A 2023-01-03   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 1821.0000 159235.0000 1 0001601830 Class A Common Stock
A 2022-10-03   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 1265.0000 157414.0000 1 0001601830 Class A Common Stock
A 2022-07-01   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 1631.0000 156149.0000 1 0001601830 Class A Common Stock
A 2022-06-14   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 18145.0000 154518.0000 1 0001601830 Class A Common Stock
A 2022-06-14   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 36290.0000 36290.0000 2 0001601830 Stock Option (right to buy)
A 2022-04-01   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 1788.0000 136373.0000 1 0001601830 Class A Common Stock
A 2022-03-31   Beam Therapeutics Inc. 4 A-Award --D 15000.0000 40065.0000 1 0001745999 Common Stock
D 2022-03-31   Beam Therapeutics Inc. 4 S-Sale --D 1787.0000 38278.0000 2 0001745999 Common Stock
A 2022-01-31   Beam Therapeutics Inc. 4 A-Award --D 30000.0000 30000.0000 1 0001745999 Stock Option (Right to Buy)
A 2022-01-03   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 763.0000 134585.0000 1 0001601830 Class A Common Stock
A 2021-10-01   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 629.0000 133822.0000 1 0001601830 Class A Common Stock
A 2021-07-01   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 382.0000 133193.0000 1 0001601830 Class A Common Stock
D 2021-06-30   Beam Therapeutics Inc. 4 M-Exempt --D 30000.0000 282941.0000 4 0001745999 Stock Option (Right to Buy)
D 2021-06-30   Beam Therapeutics Inc. 4 S-Sale --D 15000.0000 24809.0000 3 0001745999 Common Stock
D 2021-06-30   Beam Therapeutics Inc. 4 S-Sale --D 15000.0000 39809.0000 2 0001745999 Common Stock
A 2021-06-30   Beam Therapeutics Inc. 4 M-Exempt --D 30000.0000 54809.0000 1 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 19800.0000 24809.0000 8 0001745999 Common Stock
A 2021-06-28   Beam Therapeutics Inc. 4 M-Exempt --D 45000.0000 69809.0000 1 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 1100.0000 68709.0000 2 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 1880.0000 66829.0000 3 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 5220.0000 61609.0000 4 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 8907.0000 52702.0000 5 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 3290.0000 49412.0000 6 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 S-Sale --D 4803.0000 44609.0000 7 0001745999 Common Stock
D 2021-06-28   Beam Therapeutics Inc. 4 M-Exempt --D 45000.0000 312941.0000 9 0001745999 Stock Option (Right to Buy)
D 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 J-Other --D 126561.0000 0.0000 1 0001601830 Common Stock
D 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 C-Conversion --D 6250.0000 0.0000 3 0001601830 Common Stock
A 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 J-Other --D 126561.0000 126561.0000 2 0001601830 Class A Common Stock
A 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 C-Conversion --D 6250.0000 132811.0000 4 0001601830 Class A Common Stock
D 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 C-Conversion --D 12500.0000 0.0000 5 0001601830 Stock Option (Right to Buy)
D 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 C-Conversion --D 404688.0000 0.0000 7 0001601830 Stock Option (Right to Buy)
A 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 C-Conversion --D 404688.0000 404688.0000 8 0001601830 Stock Option (Right to Buy)
A 2021-04-20   RECURSION PHARMACEUTICALS, INC. 4 C-Conversion --D 12500.0000 12500.0000 6 0001601830 Stock Option (Right to Buy)
A 2021-04-16   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 6250.0000 126561.0000 1 0001601830 Common Stock
A 2021-04-15   RECURSION PHARMACEUTICALS, INC. 4 A-Award --D 12500.0000 12500.0000 2 0001601830 Stock Option (Right to Buy)
A 2021-03-31   Beam Therapeutics Inc. 4 A-Award --D 35000.0000 35000.0000 2 0001745999 Stock Option (Right to Buy)
A 2021-03-31   Beam Therapeutics Inc. 4 A-Award --D 17500.0000 24809.0000 1 0001745999 Common Stock
A 2021-01-04   Beam Therapeutics Inc. 4 M-Exempt --D 25000.0000 32309.0000 1 0001745999 Common Stock
D 2021-01-04   Beam Therapeutics Inc. 4 S-Sale --D 800.0000 31509.0000 2 0001745999 Common Stock
D 2021-01-04   Beam Therapeutics Inc. 4 S-Sale --D 1951.0000 29558.0000 3 0001745999 Common Stock
D 2021-01-04   Beam Therapeutics Inc. 4 S-Sale --D 2449.0000 27109.0000 4 0001745999 Common Stock
D 2021-01-04   Beam Therapeutics Inc. 4 S-Sale --D 6509.0000 20600.0000 5 0001745999 Common Stock
D 2021-01-04   Beam Therapeutics Inc. 4 S-Sale --D 5296.0000 15304.0000 6 0001745999 Common Stock
D 2021-01-04   Beam Therapeutics Inc. 4 S-Sale --D 7095.0000 8209.0000 7 0001745999 Common Stock

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016